Nathan McCutcheon

Nathan McCutcheon joined Shionogi Inc., a U.S. subsidiary of Shionogi & Co., Ltd., in 2019 as Executive Vice President and Chief Commercial Officer. In this role, he oversaw all aspects of the global organization’s U.S. commercial business and was a member of the Executive Committee. In 2020, after leading the U.S. commercial organization to exceed financial expectations, Nate was promoted to Chief Operating Officer with increased responsibilities across commercial operations, distribution and business development activities. In 2022, he was named President and Chief Executive Officer and a member of the Shionogi Inc. board. During his tenure, he has led Shionogi’s North American organization to achieve profitability through significant growth, driven by successful product launches, acquisitions, U.S. government awards and contracts, clinical development and regulatory milestones.

Nate brings more than 30 years of general management and commercialization experience in large, mid-sized and startup pharmaceutical companies to his role at Shionogi Inc. Prior to joining the company, he held global and U.S. leadership roles at Mallinckrodt, Allergan and Eli Lilly, among others.

 

Nate earned an MBA from the Kelley School of Business at Indiana University and a Bachelor of Science in Marketing from Ball State University.